2014•Journal of clinical and experimental medicineRequires access

The expression of growth differentiation factor-15 in heart failure induced by congenital heart disease.

LI Ze-mi

Open publisher page 0 citations

Abstract

Objective To investigate the expression of growth differentiation factor-15 in heart failure induced by congenital heart disease.Methods Sixty-two patients with heart failure induced by congenital heart disease were enrolled in our study from March 2011 to September 2011 in Bazhong central hospital. Patients were assigned into group of heart failure and group non-heart failure group according to whether complicating with heart failure or not. Plasma concentration of GDF-15 and NT-proBNP were measured by ELISA. LVEF was detected by ultrasonic cardiogram. Results The group heart failure demonstrated a significant higher plasma concentration of GDF-15 and NT-proBNP,and LVEF decreased compared with Group non-Heart Failure( P 0. 01). Conclusion Plasma concentration of GDF-15 is elevated in patients with heart failure induced by congenital heart disease. It may be a helpful auxiliary biomarker in diagnosis of heart failure induced by congenital heart disease.

About this research paper

What this paper is about

Objective To investigate the expression of growth differentiation factor-15 in heart failure induced by congenital heart disease.Methods Sixty-two patients with heart failure induced by congenital heart disease were enrolled in our study from March 2011 to September 2011 in Bazhong central hospital. Patients were assigned into group of heart failure and group non-heart failure group according to whether complicating with heart failure or not. Plasma concentration of GDF-15 and NT-proBNP were measured by ELISA. LVEF was detected by ultrasonic cardiogram. Results The group heart failure demonstrated a significant higher plasma concentration of GDF-15 and NT-proBNP,and LVEF decreased compared with Group non-Heart Failure( P 0. 01). Conclusion Plasma concentration of GDF-15 is elevated in patients with heart failure induced by congenital heart disease. It may be a helpful auxiliary biomarker in diagnosis of heart failure induced by congenital heart disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression of growth differentiation factor-15 in heart failure induced by congenital heart disease.Methods Sixty-two patients with heart failure induced by congenital heart disease were enrolled in our study from March 2011 to September 2011 in Bazhong central hospital. Patients were assigned into group of heart failure and group non-heart failure group according to whether complicating with heart failure or not. Plasma concentration of GDF-15 and NT-proBNP were measured by ELISA. LVEF was detected by ultrasonic cardiogram. Results The group heart failure demonstrated a significant higher plasma concentration of GDF-15 and NT-proBNP,and LVEF decreased compared with Group non-Heart Failure( P 0. 01). Conclusion Plasma concentration of GDF-15 is elevated in patients with heart failure induced by congenital heart disease. It may be a helpful auxiliary biomarker in diagnosis of heart failure induced by congenital heart disease.

Key concepts: Heart failure, Medicine, Ejection fraction, Cardiology, Heart disease, Internal medicine, GDF15, Biomarker

Related papers

Back to paper searchBrowse research topicsOriginal source
The expression of growth differentiation factor-15 in heart failure induced by congenital heart disease. — Research Paper | ScholarLens